Erythropoietin therapy after allogeneic hematopoietic cell transplantation: a prospective, randomized trial-Reference-Cited by-同舟云学术

Erythropoietin therapy after allogeneic hematopoietic cell transplantation: a prospective, randomized trial

Published:2014-07-03 Issue:1 Volume:124 Page:33-41
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Jaspers Aurélie¹,Baron Frédéric¹,Willems Évelyne¹,Seidel Laurence²,Hafraoui Kaoutar¹,Vanstraelen Gaetan³,Bonnet Christophe¹,Beguin Yves¹

Affiliation:

1. Department of Medicine, Division of Hematology, Centre Hospitalier Universitaire of Liège and University of Liège, Liège, Belgium;

2. Department of Statistics, University of Liège, Liège, Belgium; and

3. Department of Medicine, Division of Hematology-Oncology, Centre Hospitalier Peltzer-La Tourelle, Verviers, Belgium

Abstract

Key Points Erythropoietin therapy can be effective to hasten erythroid recovery and reduce transfusion requirements after allogeneic HCT.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/124/1/33/1379159/33.pdf

Reference34 articles.

1. Prediction of response and other improvements on the limitations of recombinant human erythropoietin therapy in anemic cancer patients.;Beguin;Haematologica,2002

2. Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin.;Beguin;Blood,1993

3. Circulating erythropoietin levels after bone marrow transplantation: inappropriate response to anemia in allogeneic transplants.;Beguin;Blood,1991

4. Dynamics of erythropoietic recovery following bone marrow transplantation: role of marrow proliferative capacity and erythropoietin production in autologous versus allogeneic transplants.;Beguin;Bone Marrow Transplant,1993

5. Erythropoiesis after nonmyeloablative stem-cell transplantation is not impaired by inadequate erythropoietin production as observed after conventional allogeneic transplantation.;Baron;Transplantation,2002

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Miscellaneous Complications of Chimeric Antigen Receptor T-Cell Therapy;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

2. Non-prise de greffe, dysfonctionnement du greffon et érythroblastopénie : mise à jour des définitions, outils diagnostiques et prise en charge : recommandation de la SFGM-TC;Bulletin du Cancer;2023-02

3. Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant;American Journal of Hematology;2021-08-24

4. New Approaches to Allogeneic Haematopoietic Cell Transplantation;Oncology & Haematology;2021

5. Acute Complications in Stem Cell Transplantation;Contemporary Bone Marrow Transplantation;2021